Skip to content
Screener

Opko Health OPK Diagnostics — Intangible Amortization

Other segment segments

Pharmaceutical
$16.44M+0.1%

Similar metrics at other companies

lululemon athletica logo
LULUAmericas — Intangible Amortization
$0
AeroVironment logo
AVAVUxs — Intangible Amortization
$4.26M
Restoration Hardware logo
RHRH — Intangible Amortization
-$30K-42.9%
Hasbro logo
HASEntertainment — Intangible Amortization
$4.2M-10.6%
TFI
TFINBanking — Intangible Amortization
$269K-30.1%
TFI
TFINFactoring — Intangible Amortization
$111K-42.5%

Other financials

Income statement

See full
Revenue$163.6M+4.3%
Gross profit$80.0M+62.0%
Operating income-$7.0M+88.4%
Net income-$8.4M+94.3%
EPS (diluted)-$0.01+94.7%

Balance sheet

See full
Cash & equivalents$40.6M-62.5%
Total debt$49.9M-7.5%
Total equity$1.2B-8.7%
Total assets$1.8B-7.3%

Cash flow

See full
Operating cash flow-$43.5M+47.9%
CapEx$3.0M-8.5%
Free cash flow-$46.5M+46.4%

Valuation

See full
Market cap$985.15M-2.3%
P/S1.7×+0.2×

Profitability

See full
Gross margin40.8%+8.1pp
Operating margin-8.2%-3.5pp
Net margin-12.4%-4.3pp
FCF margin-22.8%-6.7pp

Returns & leverage

See full
Return on equity-5.9%-2.1pp
Debt / equity0.0×
Current ratio3.3×-0.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The source filing: Opko Health’s 10-Q, filed July 27, 2026.

Filed
Jul 27, 2026, 4:12 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-318090
(In thousands) / Revenue from services: / PharmaceuticalFor the three months ended June 30, 2026 / —For the three months ended June 30, 2025 / —For the six months ended June 30, 2026 / —For the six months ended June 30, 2025 / —
$33,166$30,342$62,365$61,183
Amortization of intangible assets:
Pharmaceutical$16,436$16,415$32,869$32,525
Diagnostics2,5333,0295,0666,779
Corporate
$18,969$19,444$37,935$39,304
Other segment items:
Pharmaceutical$—$—$—$—

Item 1. Financial Statements

FAQ

What is Opko Health's diagnostics — intangible amortization?
Opko Health (OPK) reported diagnostics — intangible amortization of $2.53M in Q2 2026.
How has Opko Health's diagnostics — intangible amortization changed year-over-year?
Opko Health's diagnostics — intangible amortization decreased by 16.4% year-over-year, from $3.03M to $2.53M.
What is the long-term trend for Opko Health's diagnostics — intangible amortization?
Over 3 years (2022 to 2025), Opko Health's diagnostics — intangible amortization has grown at a -19.8% compound annual growth rate (CAGR), from $23.87M to $12.3M.
What does diagnostics — intangible amortization mean?
Represents the systematic allocation of the cost of intangible assets, such as acquired customer lists, patents, or proprietary technology, over their useful lives within the diagnostics segment. This non-cash expense reflects the consumption of acquired intellectual property. It is a key factor in reconciling the difference between operating income and cash flow.

Ask your AI about Opko Health's diagnostics — intangible amortization.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude